Ibritumomab tiuxetan radioimmunotherapyfor patients with relapsed or refractory non-Hodgkin Lymphoma and mild thrombocytopenia: a phase II multicenter trial - Wiseman, GA; Gordon, LI; Multani, PS (Blood, 2002)
et al.